November, 2009LexisNexis® Legal News Podcast for November 16, 2009
Eli Lilly settles off-label Zyprexa claims with Utah for $24 million, and, two Ohio class actions assert consumer claims over misbranded cold products. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Continue →IDS Sports Dietary Supplements Recalled for Steroids, Liver Injury Risks
Dietary supplements made by IDS Sports are being recalled because they contain steroids not listed on the labeling and may cause acute liver injury and other serious health problems, the Food and Drug Administration said.
Continue →Alcoholic Drinks With Caffeine Under FDA Scrutiny
Beverages that combine alcohol and caffeine may be illegal and unsafe for consumers, the Food and Drug Administration said today in announcing an investigation into the products.
Continue →Pieces of Metal, Plastic, Other Trash Found in Genzyme Drugs, FDA Warns
Five drug products made by Genzyme Corp. and used to treat a variety of life-threatening diseases may be contaminated with tiny fragments of stainless steel, plastic, and other foreign materials that pose a risk of serious injury and death to patients, the Food and Drug Administration said.
Continue →Reports of Cartilage Damage in Post-Surgery Anesthetic Patients
Dozens of patients given certain localized pain killers following surgery have developed chondrolysis, a condition marked by the destruction of articular cartilage in the shoulder or other joints, the Food and Drug Administration is warning.
Continue →Homelite Backpack Blowers Recalled Due to Leaking Fuel, Fire Hazard
They may produce the most annoying noise in the world, but about 85,000 Homelite backpack blowers commonly used by gardeners in place of brooms may leak gasoline, posing a fire and injury risk.
Continue →LexisNexis® Legal News Podcast for November 13, 2009
The North Carolina Supreme Court says big tobacco need not pay Pa. and Md. tobacco farmers anymore, and, AARP is sued over health care insurance marketing strategies. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Continue →Pai You Guo, Marketed as Dietary Supplement – Recall
Audience: Consumers
GMP Herbal Products and FDA notified consumers and healthcare professionals of a recall of Pai You Guo, a weight loss dietary supplement, due to the presence of undeclared drug ingredients. FDA lab analyses of dietary…
Local Anesthetics, Continuously Infused (marketed as bupivacaine, chloroprocaine, lidocaine, mepivacaine, procaine, ropivacaine) – Chondrolysis
Audience: Orthopedic and Anesthesia healthcare professionals, hospital risk managers
FDA notified healthcare professionals of 35 reports of chondrolysis (necrosis and destruction of cartilage) in patients given continuous intra-articular…
Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
Audience: Endocrinological and Genetics Medicine healthcare professionals
FDA and Genzyme notified healthcare professionals about the potential for foreign particle contamination of several products that are used to treat rare, serious, and…
Recent Related Features
All Stories
facebook
rss
twitter